UK +44 (0)1223 491486      USA toll free 1-866 877 2185

10 06, 2021

pep talk June 2021

By |2021-06-16T11:06:31+00:00June 10th, 2021|news, Uncategorized|Comments Off on pep talk June 2021

I’d like to personally thank our amazing customers and collaborators who have supported Qkine since we span out of Cambridge University nearly 5 years ago to add a dose of innovation and improve reliability in the growth factor supply chain...and yes we are planning a huge celebration in November, watch this [...]

10 03, 2021

pioneering proteins launch

By |2021-03-12T13:00:44+00:00March 10th, 2021|news, protein engineering, protein science|Comments Off on pioneering proteins launch

We are proud to launch our Pioneering Protein range! A range of modified proteins have been carefully developed by world leading academic laboratories, licenced through Cambridge Enterprise, and then manufactured to our high purity and bioactivity standards, bringing together academic innovation with high level manufacturing purity. Folloistatin-resistant activin A (FRACTA) has been developed by our [...]

8 03, 2021

Celebrating International Women’s Day 2021 with our amazing team, collaborators, customers and wider network

By |2021-03-10T14:20:30+00:00March 8th, 2021|news|Comments Off on Celebrating International Women’s Day 2021 with our amazing team, collaborators, customers and wider network

At Qkine we are so proud of all the wonderful women we work with! This #InternationalWomensDay we want to celebrate our amazing network and empower #WomenInSTEM to learn from and help each other #empoweringwomen #womenpower

8 03, 2021

Catherine Elton, Qkine founder and CEO, recognised in the #21towatch in 2021

By |2021-03-08T17:47:55+00:00March 8th, 2021|awards, news|Comments Off on Catherine Elton, Qkine founder and CEO, recognised in the #21towatch in 2021

The #21toWatch campaign showcases 7 people, 7 companies and 7 inventions at the forefront of innovation in Cambridge and the East of England. The results were announced on the 4th March and we are delighted that our CEO, Catherine Elton, was named one of the 7 “people” to watch.

25 11, 2020

Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

By |2020-11-25T15:00:51+00:00November 25th, 2020|animal-free, news, organoid news|Comments Off on Qkine, with UK biotechnology companies Manchester BIOGEL and Cellesce, is developing fully synthetic animal-free scaffolds to overcome barriers in sustainable and scalable organoid culture, in a project funded by Innovate UK

Qkine, Manchester BIOGEL and Cellesce have been awarded Innovate UK Sustainable Innovation Funding to develop fully synthetic, chemically-defined three-dimensional (3D) scaffolds to enable manufacture scale up and improve reproducibility of patient-derived organoids.

11 11, 2020

Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards

By |2020-11-11T12:05:36+00:00November 11th, 2020|awards, news|Comments Off on Qkine shortlisted in the Cambridge Independent 2020 Science & Technology awards

Qkine is delighted to have been shortlisted in the prestigious Cambridge Independent 2020 Science and Technology Awards. Sponsored by Kao Data, the Startup of the Year shortlist recognises "early-stage companies that show entrepreneurial drive to solve a problem, or improve on what is already out there". Qkine would like to extend its congratulations [...]

9 11, 2020

Organoid Q&A with industry experts from the HUB, CSHL and Stemnovate

By |2020-12-08T16:33:07+00:00November 9th, 2020|organoid news, quality, resources|Comments Off on Organoid Q&A with industry experts from the HUB, CSHL and Stemnovate

We recently held a webinar with CytoSMART and organoid pioneers from Cold Spring Harbor Laboratory, Stemnovate and the Hubrecht Organoid Technology titled: what's needed to realize the potential of organoids? Following presentations from our speakers, we held an insightful Q&A session to address key challenges and questions from the audience. In this blog post, [...]

14 10, 2020

On-demand webinar: What’s needed to realise the potential of organoids?

By |2020-11-10T16:07:01+00:00October 14th, 2020|organoid news, quality, resources|Comments Off on On-demand webinar: What’s needed to realise the potential of organoids?

From standardization of imaging techniques, to more reproducible and cost-effective organoid culture media Organoids have the potential to revolutionize current drug discovery approaches, enhance the physiological relevance of in vitro disease models, and deliver on the promise of precision medicine. But, as with any new technology, there are a number of hurdles to overcome as [...]

26 08, 2020

Implementing animal-free recombinant proteins into stem cell supply chains

By |2020-11-11T11:12:23+00:00August 26th, 2020|animal-free, protein engineering, quality, stem cells|Comments Off on Implementing animal-free recombinant proteins into stem cell supply chains

Most industries today are under pressure to switch to more ethical and sustainable animal-free alternatives, and now the trend is coming to stem cell labs. As stem cell applications accelerate towards the clinic, novel drug discovery platforms are rapidly scaled, and new transformative stem cell-based technologies such as cultured meat arise, there is [...]

21 07, 2020

Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board

By |2020-12-08T16:06:23+00:00July 21st, 2020|news, press release|Comments Off on Rob Nixon joins Qkine as Head of Commercial and Dr Cassie Doherty is appointed to the board

Cambridge, UK 21 July 2020: Qkine – a specialist developer and manufacturer of proteins for stem cell, organoid and regenerative medicine applications – is delighted to announce the appointment of Rob Nixon to its management team as Head of Commercial and Dr Cassie Doherty, Investment Director at Parkwalk, to its board. With years of [...]

Go to Top